Mini Curriculum Vitae

PICARD Nicolas
Nicolas PICARD

Chargé de recherche CNRS
https://orcid.org/0000-0002-1695-3389
Doctorat de l’Université de Paris 6 (Pierre et Marie Curie) 2006

Précédents laboratoires :
CNRS ERL 8228 Métabolisme et physiologie rénale, Paris (Directeur : Aurélie Edwards) 2013-2018

PARCC - Paris Centre de recherche Cardiovasculaire (PARCC) – INSERM UMR 970
Equipe 12 : « Pathophysiologie du tubule rénal, homéostasie et pression artérielle »
(Directeur : Dominique Eladari) 2012-2013

CNRS ERL 7226 ; Centre de recherche des Cordeliers (Directeur : Alain Doucet), Paris 2010-2012

Institute of Anatomy, Zurich, Switzerland 2007-2010
Encadrant : Pr Johannes Loffing

Institute of Anatomy, Zurich, Switzerland 2006-2007
Encadrant : Pr Brigitte Kaissling

Nicolas Picard (Lab for tissue biology and therapeutic engineering, Lyon, UMR5305 CNRS) is a specialist in kidney morphology and in regulatory mechanisms of renal ion transport. He recently joined the group in Lyon where he develops projects on organ architecture maintenance and its functional integrity (kidney, skin) in adults. He published about 35 articles mainly on ion transport regulation in the distal nephron. His recent research work focus on the participation of renal intercalated cells to NaCl and H+ handling. He also investigates signaling pathways by using high throughtput techniques on isolated nephron segment and renal cells.

Mots clés : Homéostasie du sodium et troubles électrolytique, Physiologie rénale Microcirculation cutanée

Equipe : Intégrité Fonctionnelle du Tissu Cutané
Courriel : nicolas.picard@ibcp.fr
Téléphone : +33(0)4-37-65-29-34
Statut : Chargé de recherches

54 publications au total. Seules les 5 dernières années sont affichées

2019
54.  TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells. 
Arhatte M, Gunaratne Gs, El Boustany C, Kuo Iy, Moro C, Duprat F, Plaisant M, Duval H, Li D, Picard N, Couvreux A, Duranton C, Rubera I, Pagnotta S, Lacas-gervais S, Ehrlich Be, Marchant Js, Savage Am, Van Eeden Fjm, Wilkinson Rn, Demolombe S, Honore E, Patel A
(2019) Nat Commun 10 :2024-2024  Icon PUBMED

2017
53.  Editorial. 
Becquemont L, Picard N, Verstuyft C
(2017) Therapie 72 :173-174  Icon PUBMED

52.   
Becquemont L, Picard N, Verstuyft C
(2017) Therapie 72 :171-172  Icon PUBMED

51.  Cutaneous and renal vasodilatory response to local pressure application: A comparative study in mice. 
Begey Al, Liu Kl, Lo M, Josset-lamaugarny A, Picard N, Gauthier C, Fromy B, Sigaudo-roussel D, Dubourg L
(2017) Microvasc Res 115 :44-51  Icon PUBMED

50.  Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship. 
Deppenweiler M, Falkowski S, Saint-marcoux F, Monchaud C, Picard N, Laroche Ml, Tubiana-mathieu N, Venat-bouvet L, Marquet P, Woillard Jb
(2017) Pharmacol Res 121 :138-144  Icon PUBMED

49.  Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer. 
El Balkhi S, Chaslot M, Picard N, Dulaurent S, Delage M, Mathieu O, Saint-marcoux F
(2017) Int J Legal Med 131 :979-988  Icon PUBMED

48.  The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. 
Hennings Jc, Andrini O, Picard N, Paulais M, Huebner Ak, Cayuqueo Ik, Bignon Y, Keck M, Corniere N, Bohm D, Jentsch Tj, Chambrey R, Teulon J, Hubner Ca, Eladari D
(2017) J Am Soc Nephrol 28 :209-217  Icon PUBMED

47.  Intercalated Cell Depletion and Vacuolar H(+)-ATPase Mistargeting in an Ae1 R607H Knockin Model. 
Mumtaz R, Trepiccione F, Hennings Jc, Huebner Ak, Serbin B, Picard N, Ullah Akms, P?unescu Tg, Capen De, Lashhab Rm, Mouro-chanteloup I, Alper Sl, Wagner Ca, Cordat E, Brown D, Eladari D, Hubner Ca
(2017) J Am Soc Nephrol 28 :1507-1520  Icon PUBMED

46.  Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx). 
Picard N, Boyer Jc, Etienne-grimaldi Mc, Barin-le Guellec C, Thomas F, Loriot Ma,
(2017) Therapie 72 :185-192  Icon PUBMED

45.   
Picard N, Boyer Jc, Etienne-grimaldi Mc, Barin-le Guellec C, Thomas F, Loriot Ma,
(2017) Therapie 72 :175-183  Icon PUBMED

44.  Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx). 
Woillard Jb, Chouchana L, Picard N, Loriot Ma,
(2017) Therapie 72 :285-299  Icon PUBMED

43.   
Woillard Jb, Chouchana L, Picard N, Loriot Ma,
(2017) Therapie 72 :269-284  Icon PUBMED